Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Medtech Ventures | Endovascular Aneurysm Repair Device Market Paradigm Shift & Strategic Opportunities

Endovascular Aneurysm Repair Device Market Paradigm Shift & Strategic Opportunities

The global market for endovascular aneurysm repair devices was estimated at $1,750 million in 2008, a growth rate of 17% over its 2007 level of $1,500 million. Over the past five years the market has been growing at a compound average annual growth rate (CAAGR) of 18%.

The primary customers and decision makers for aortic and peripheral endovascular aneurysm repair devices are endovascular surgeons, a target market fairly well defined with estimates of 2,500 active practitioners worldwide.

The primary customers and decision makers for cerebral endovascular aneurysm repair devices are interventional neuroradiologists, a target market even better defined with estimates of 1,000 active practitioners worldwide.

From the industry perspective, the market for endovascular aneurysm repair is segmented along aneurysm location with most companies present in one segment and non-existent in other segments.

With aneurysm research pointing towards common pathological pathways for aneurysm initiation, progression and rupture, a new vision of a unified market is emerging where economies of scale can be achieved.

Medtech Ventures' Endovascular Aneurysm Repair Device Market - Paradigm Shift & Strategic Opportunities Report examines a unified landscape of $1.8 billion market for endovascular aneurysm remodeling and repair, regardless of location, and uncovers the hidden opportunities that such market unification offers to stakeholders.

Endovascular Aneurysm Repair Device Market - Paradigm Shift & Strategic Opportunities Report reviews recent scientific thinking and technological breakthroughs. The report calculates leading companies market shares and competitive positions in the yet to be unified market and offers a first glimpse of the shape of things to come with forecasts to 2015.

If you still believe that the market for endovascular aneurysm repair is location specific, this is your chance to experiment with a new view of the market that is bound to change its strategic landscape.

With Endovascular Aneurysm Repair Device Market - Paradigm Shift & Strategic Opportunities Report, you'll be able to better:

Assess market size, growth potential and hidden synergies.

Identify emerging technologies and the companies behind them.

Leverage your own technology and brain storm new business opportunities.

Understand current market dynamics, competitors' positions and market shares.

Assess market potential and have access to forecasts till 2015.

Monitor the competition's marketed and in-development products.

Investigate mergers, acquisitions and licensing possibilities.

Get a feel of the magnitude of the opportunity that arterial remodeling technologies present and contemplate your company's position towards this market disrupting technology.

Written with senior executives in mind, Endovascular Aneurysm Repair Device Market - Paradigm Shift & Strategic Opportunities Report is a short insightful document worth contemplating.

Date Published: February 2009

Number of Pages: 70

Table of Contents

Price

PDF Single User $3900.00

PDF Site Licence $7800.00

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions